Beata Błażejewska-Hyżorek

Beata Błażejewska-Hyżorek

Auto-generated profile, based on publicly available information

Beata Błażejewska-Hyżorek

2nd Department of Neurology, Institute of Psychiatry and Neurology, Warszawa, Poland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
MKMariusz Kusztal
Mariusz Kusztal
MKMariusz Kłopotowski
Mariusz Kłopotowski
Stanislawa Bazan-SochaStanislawa Bazan-Socha
Stanislawa Bazan-Socha
BBBeata Błażejewska-Hyżorek
Beata Błażejewska-Hyżorek
KPKrzysztof Pawlaczyk
Krzysztof Pawlaczyk
Michal NowickiMichal Nowicki
Michal Nowicki
Fabry disease (FD) is an X-linked disorder related to a deficiency of the lysosomal enzyme alpha-galactosidase A. In Poland, enzyme replacement therapy (ERT) for FD is offered by the National Health Fund only at selected hospital infusion centers. Patients with FB are considered at a high risk of developing complications from COVID-19. Some patients omitted infusions due to fear of infection or outbreaks in hospitals. Lack of alternative infusion sites hampered the situation. To analyze the impact of the SARS-CoV-2 pandemic on FD patients, especially their fears and expectations, the Polish FD Collaborative Group collaborated on a survey project. Between September and November 2020, we distributed a customized survey exploring expectations and fears among FD subjects. Fifty-five individuals (35 receiving ongoing ERT) from different FD centers completed the study. The median age was 40 years [IQR 25; 50], and gender distribution was almost equal (27 F; 28 M). One-fourth of FD patients reported severe disability limiting transportation for infusions that, in the opinion of the other 25% of responders, consumed >4 h. Forty-four (80%) of all would prefer home infusions performed by a nurse (n = 37, 67.3%) or by a trained non-medical person (n = 7, 12.7%), while 8 (14.5%) patients would choose a local hospital. As expected, transportation time (in one direction) was longer in those preferring home infusions (89.4 ±63 vs 36.2 ±67 min; p = 0.02). Also, those with more severe FD manifestation would prefer home infusions to treatment in FD centers (p = 0.03). The vast majority of respondents (n = 46; 83%) would not change their preferences after pandemic termination. To maintain ERT, FD patients prefer home infusions or those given in the nearest hospital, especially during a pandemic.

1 January 2020 in Folia Neuropathologica
Verified
Journal Article
Open access
PDF file
TWTeresa Wierzba-Bobrowicz
Teresa Wierzba-Bobrowicz
ELEliza Lewandowska
Eliza Lewandowska
PFPaulina Dorota Felczak
Paulina Dorota Felczak
Tomasz StępieńTomasz Stępień
Tomasz Stępień
AAAlbert Acewicz
Albert Acewicz
WGWiesława Grajkowska
Wiesława Grajkowska
Herpes simplex encephalomyelitis (HSE) is a rare disease with a high mortality rate. Correct diagnosis is established on the basis of the combination of the clinical and investigative features. Unfortunately, precise diagnosis remains difficult due to several clinical similarities and false...